Exact(2)
CONCLUSIONS Although some individuals may benefit from twice-daily dosing, the most suitable routine starting schedule for detemir in a basal-bolus regimen for type 1 diabetes is once-daily injection.
Eleven of 12 subjects (92 %) reported at least one AE during DTG + EFV dosing; the most frequently reported AEs were dizziness [11 subjects (92 %)] and abnormal dreams [5 subjects (42 %)], which were considered by the investigator to be related to EFV based on its known psychiatric side effect profile.
Similar(58)
"Less than 15 percent succeeded in dosing in the most efficient way," Dr. Wolf said.
At much higher doses, the most frequently observed effects, consistent with the primary pharmacological action of the drug, are elevation of blood pressure, a slight anxiogenic action, and increased frequency of urination.
So far, the most effective and safe dose of fibrinolytic agent administered directly into the pericardial space is unknown as well as the regiment of treatment (number of doses, intervals between doses, the most effective agent).
For each dose, the most common ages at vaccination were listed.
When these temporal effects were equated against drug dose, the most striking effect on M30 antigen levels occurred at the 4/6-h time point.
Inoculum dose: The most predominant clones of S. aureus field isolates (SA1 and SA2) were selected based on characterization profile to challenge the mice.
A sensitivity analysis showed that when the price was reduced to €85 per dose, the most efficient coverage rate increased to 69.5%.
In terms of radiation dose, the most likely culprit was I, a copious product of nuclear fission with an 8.1-day half-life.
At this dose, the most common adverse effects included low grade anemia, proteinuria, fatigue, and increase in ALT, AST, and creatinine.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com